Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Other Non-Current Assets (2016 - 2025)

Mimedx's Other Non-Current Assets history spans 14 years, with the latest figure at $7.3 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 8.37% year-over-year to $7.3 million; the TTM value through Dec 2025 reached $7.3 million, up 8.37%, while the annual FY2025 figure was $7.3 million, 8.37% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $7.3 million at Mimedx, up from $3.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $7.3 million in Q4 2025 and bottomed at $146000.0 in Q2 2023.
  • The 5-year median for Other Non-Current Assets is $291500.0 (2021), against an average of $1.3 million.
  • The largest annual shift saw Other Non-Current Assets crashed 85.95% in 2021 before it skyrocketed 3174.15% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $186000.0 in 2021, then decreased by 20.43% to $148000.0 in 2022, then surged by 38.51% to $205000.0 in 2023, then surged by 3174.15% to $6.7 million in 2024, then grew by 8.37% to $7.3 million in 2025.
  • Per Business Quant, the three most recent readings for MDXG's Other Non-Current Assets are $7.3 million (Q4 2025), $3.0 million (Q3 2025), and $990000.0 (Q2 2025).